e-learning
resources
Vienna 2012
Monday, 03.09.2012
Asthma treatment: efficacy and safety
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
M. Szabo, J. Chlumsky, R. Maykut, P. Georgiou, C.W. Chen, G. Peachey (Edelény, Hungary; Prague, Czech Republic; Basel, Switzerland; Horsham, United Kingdom; East Hanover, United States Of America)
Source:
Annual Congress 2012 - Asthma treatment: efficacy and safety
Session:
Asthma treatment: efficacy and safety
Session type:
Thematic Poster Session
Number:
2087
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Szabo, J. Chlumsky, R. Maykut, P. Georgiou, C.W. Chen, G. Peachey (Edelény, Hungary; Prague, Czech Republic; Basel, Switzerland; Horsham, United Kingdom; East Hanover, United States Of America). Physician assessment of asthma control in patients receiving omalizumab in a real-world setting. Eur Respir J 2012; 40: Suppl. 56, 2087
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting
Source: International Congress 2017 – Asthma management
Year: 2017
Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting
Source: International Congress 2017 – Asthma management
Year: 2017
Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Control of persistent asthma patients on inhaled corticosteroids in a real-life setting
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Suboptimal asthma control in patients receiving long-term maintenance therapy
Source: Annual Congress 2006 - The challenges of managing asthma in primary care
Year: 2006
Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Cost analysis for patients with severe asthma receiving omalizumab treatment
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Does the provision of a written action plan in the emergency department (ED) improve adherence to physicians‘ recommendations and asthma control in children with acute asthma? A randomized controlled trial
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Assessment and therapy for COPD patients in real-life primary care
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Cost effectiveness of omalizumab in Swedish asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006
Real-life effectiveness of omalizumab in difficult-to-treat
versus
severe asthma: a national cohort study in Belgium
Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018
Year: 2019
Can Internet-based management improve asthma control? A long term randomised clinical study of 300 asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 44s
Year: 2005
Implementation of questionnaires in the management of asthma patients in clinical practice
Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients
Year: 2013
Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 49s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept